Skip to main content
. 2022 Oct 26;83(1):20–27. doi: 10.1158/0008-5472.CAN-22-1492

Figure 1.

Figure 1. Overview of this study. A graphical overview of germline–somatic association analyses. SNP, single-nucleotide polymorphism; QC, quality control; BRCA, breast cancer; UCEC, uterine endometrial carcinoma; SKCM, skin cutaneous melanoma; PRAD, prostate cancer; GBM, glioblastoma multiforme; HNSC, head and neck squamous cell carcinoma; COADREAD, colorectal cancer; CESC, cervical cancer; OV, ovarian serous carcinoma; ESCA (EA), esophageal adenocarcinoma; ESCA (BEEA), esophageal adenocarcinoma and Barrett's esophagus; LUAD, lung adenocarcinoma; LUSC, lung squamous cell carcinoma; LUCA, lung cancer; SCNA, somatic copy-number alteration; LOH, loss of heterozygosity.

Overview of this study. A graphical overview of germline–somatic association analyses. CESC, cervical cancer; COADREAD, colorectal cancer; ESCA (BEEA), esophageal adenocarcinoma and Barrett's esophagus; ESCA (EA), esophageal adenocarcinoma; GBM, glioblastoma multiforme; HNSC, head and neck squamous cell carcinoma; LUAD, lung adenocarcinoma; LUCA, lung cancer; LUSC, lung squamous cell carcinoma; OV, ovarian serous carcinoma; PRAD, prostate cancer; QC, quality control; SKCM, skin cutaneous melanoma; SNP, single-nucleotide polymorphism; UCEC, uterine endometrial carcinoma.